GLP-1 drugs like Ozempic have transformed weight loss in the U.S., with nearly 12% of Americans having tried them, according to a new RAND report. Usage is especially high among women aged 50 to 64, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results